{"id":"intralipid-20-i-v-fat-emulsion","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertriglyceridemia"},{"rate":null,"effect":"Lipemia"},{"rate":null,"effect":"Thrombophlebitis at infusion site"},{"rate":null,"effect":"Allergic reactions"},{"rate":null,"effect":"Hepatomegaly"},{"rate":null,"effect":"Splenomegaly"}]},"_chembl":{"chemblId":"CHEMBL2108408","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Intralipid 20% is a lipid emulsion composed of soybean oil, egg yolk phospholipids, glycerin, and water that delivers energy-dense nutrition intravenously. It supplies essential fatty acids (linoleic and alpha-linolenic acid) and calories to patients who cannot receive adequate nutrition orally or enterally. The emulsion is metabolized similarly to chylomicrons, providing both caloric support and prevention of essential fatty acid deficiency.","oneSentence":"Intralipid is an intravenous fat emulsion that provides essential fatty acids and calories as a parenteral nutrition source.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:16:38.936Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parenteral nutrition support in patients unable to receive adequate oral or enteral nutrition"},{"name":"Prevention of essential fatty acid deficiency"}]},"trialDetails":[{"nctId":"NCT07362446","phase":"PHASE2","title":"Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Nyrada Pty Ltd","startDate":"2026-04-16","conditions":"Myocardial Infarction, Reperfusion Injury, AMI","enrollment":300},{"nctId":"NCT03968822","phase":"PHASE4","title":"Intralipid® 20% for Reversal of Local Anesthetics","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-07-26","conditions":"Anesthesia, Local","enrollment":18},{"nctId":"NCT04832009","phase":"EARLY_PHASE1","title":"Reversing Glucose and Lipid-mediated Vascular Dysfunction","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-05-09","conditions":"Blood Pressure, Hypertension","enrollment":46},{"nctId":"NCT02240498","phase":"PHASE1","title":"Safety and Feasibility Study of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess Cavities","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2014-09","conditions":"Abscess","enrollment":21},{"nctId":"NCT03563222","phase":"PHASE4","title":"Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age","status":"TERMINATED","sponsor":"Fresenius Kabi","startDate":"2019-12-18","conditions":"Malnutrition, Child","enrollment":1},{"nctId":"NCT05181514","phase":"NA","title":"Impact of Plasma Lipids on β Cell Function and Insulin Sensitivity","status":"COMPLETED","sponsor":"Azienda Ospedaliero, Universitaria Pisana","startDate":"2019-04-30","conditions":"Hypertriglyceridemia, Glucose Intolerance","enrollment":12},{"nctId":"NCT01679561","phase":"PHASE4","title":"Intralipid Therapy for Recurrent Implantation Failure and Recurrent Miscarriages: Is it a Hope or Myth?A Randomized Clinical Trial","status":"WITHDRAWN","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2012-02","conditions":"Pregnancy Complicated by Low Implantation","enrollment":""},{"nctId":"NCT02357576","phase":"PHASE3","title":"Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2016-05-21","conditions":"Cholestasis","enrollment":22},{"nctId":"NCT02365285","phase":"PHASE1, PHASE2","title":"Racial Differences in Vagal Control of Glucose Homeostasis","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2015-03","conditions":"Obesity","enrollment":23},{"nctId":"NCT02406586","phase":"NA","title":"Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)","status":"COMPLETED","sponsor":"Emory University","startDate":"2009-07","conditions":"Hypertension, Diabetes","enrollment":36},{"nctId":"NCT00672854","phase":"PHASE2, PHASE3","title":"Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN","status":"COMPLETED","sponsor":"Emory University","startDate":"2008-11","conditions":"Parenteral Nutrition","enrollment":100},{"nctId":"NCT00589888","phase":"NA","title":"FFA-Induced Hypertension and Endothelial Dysfunction","status":"COMPLETED","sponsor":"Emory University","startDate":"2006-08","conditions":"Endothelial Dysfunction, Hypertension","enrollment":13},{"nctId":"NCT02865785","phase":"PHASE1, PHASE2","title":"Effect of Intralipid Infusion in Patients With Recurrent Implantation Failure","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2016-07","conditions":"Subfertility","enrollment":320}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Intralipid 20% I.V. Fat Emulsion","genericName":"Intralipid 20% I.V. Fat Emulsion","companyName":"University of Michigan","companyId":"university-of-michigan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intralipid is an intravenous fat emulsion that provides essential fatty acids and calories as a parenteral nutrition source. Used for Parenteral nutrition support in patients unable to receive adequate oral or enteral nutrition, Prevention of essential fatty acid deficiency.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}